High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver(Center for Cancer Research), Vikram Pattanayak(Center for Cancer Research), Michelle S. Prew(Center for Cancer Research), Shengdar Q. Tsai(Harvard University), Nathalie T. Nguyen(Center for Cancer Research), Zongli Zheng(City University of Hong Kong), J. Keith Joung(Massachusetts General Hospital)
Cited by 2,674Open Access